Terms: = Sarcomas AND FGFR3, CD333, 2261, ENSG00000068078, P22607, JTK4, ACH, HSFGFR3EX, CEK2
45 results:
1. Receptor tyrosine kinase gene expression profiling of orbital rhabdomyosarcoma unveils MET as a potential biomarker and therapeutic target.
Chauhan S; Sen S; Irshad K; Kashyap S; Pushker N; Meel R; Sharma MC
Hum Cell; 2024 Jan; 37(1):297-309. PubMed ID: 37914903
[TBL] [Abstract] [Full Text] [Related]
2. FGF2 drives osteosarcoma metastasis through activating FGFR1-4 receptor pathway-mediated ICAM-1 expression.
Huang YC; Chen WC; Yu CL; Chang TK; I-Chin Wei A; Chang TM; Liu JF; Wang SW
Biochem Pharmacol; 2023 Dec; 218():115853. PubMed ID: 37832794
[TBL] [Abstract] [Full Text] [Related]
3. Retroperitoneal liposarcoma and craniosynostosis: possible genomic relationship, case report, and literature review.
Sguinzi RM; Aissaoui S; Genevay-Infante M; Breguet R; Charbonnet P; Francis K; Kini R; Bühler L
Funct Integr Genomics; 2022 Dec; 23(1):8. PubMed ID: 36538187
[TBL] [Abstract] [Full Text] [Related]
4. Prevalence of NTRK Fusions in Canadian Solid Tumour Cancer Patients.
Silvertown JD; Lisle C; Semenuk L; Knapp C; Jaynes J; Berg D; Kaul N; Lachapelle J; Richardson L; Speevak M; Sarras H; Berman DM; Carter R; Feilotter H; Feltis T
Mol Diagn Ther; 2023 Jan; 27(1):87-103. PubMed ID: 36194351
[TBL] [Abstract] [Full Text] [Related]
5. Molecular and clinicopathological analysis revealed an immuno-checkpoint inhibitor as a potential therapeutic target in a subset of high-grade myxofibrosarcoma.
Yamashita A; Suehara Y; Hayashi T; Takagi T; Kubota D; Sasa K; Hasegawa N; Ishijima M; Yao T; Saito T
Virchows Arch; 2022 Oct; 481(4):1-17. PubMed ID: 35705750
[TBL] [Abstract] [Full Text] [Related]
6. Managing patients with advanced soft tissue sarcoma: Evolving landscape from an Australian perspective.
Bae S; Brnabic A; Crowe P; Carey-Smith R; Andelkovic V; Singhal N; Stalley P; Yip D; Desai J
Asia Pac J Clin Oncol; 2022 Dec; 18(6):605-613. PubMed ID: 35098667
[TBL] [Abstract] [Full Text] [Related]
7. Epithelioid sarcoma: A single-institutional retrospective cohort study of 36 cases.
Zhang S; Jing C; Liu H; Zhao Z; Zhang X; Liu T; Xu S; Xu L; Yu S
J Orthop Surg (Hong Kong); 2021; 29(3):23094990211029349. PubMed ID: 34405755
[TBL] [Abstract] [Full Text] [Related]
8. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in the Childhood Cancer Survivor Study.
Kim J; Gianferante M; Karyadi DM; Hartley SW; Frone MN; Luo W; Robison LL; Armstrong GT; Bhatia S; Dean M; Yeager M; Zhu B; Song L; Sampson JN; Yasui Y; Leisenring WM; Brodie SA; de Andrade KC; Fortes FP; Goldstein AM; Khincha PP; Machiela MJ; McMaster ML; Nickerson ML; Oba L; Pemov A; Pinheiro M; Rotunno M; Santiago K; Wegman-Ostrosky T; Diver WR; Teras L; Freedman ND; Hicks BD; Zhu B; Wang M; Jones K; Hutchinson AA; Dagnall C; Savage SA; Tucker MA; Chanock SJ; Morton LM; Stewart DR; Mirabello L
JNCI Cancer Spectr; 2021 Apr; 5(2):. PubMed ID: 34308104
[TBL] [Abstract] [Full Text] [Related]
9. Clinical characteristics and successful treatment outcomes of children and adolescents with Kaposi sarcoma in Southwestern Tanzania.
Campbell LR; El-Mallawany NK; Slone JS; Malingoti BM; Mehta PS; Scheurer ME; Bacha JM; Peckham-Gregory EC
Pediatr Hematol Oncol; 2022 Feb; 39(1):28-47. PubMed ID: 34243680
[TBL] [Abstract] [Full Text] [Related]
10. ETV4 and ETV5 drive synovial sarcoma through cell cycle and DUX4 embryonic pathway control.
DeSalvo J; Ban Y; Li L; Sun X; Jiang Z; Kerr DA; Khanlari M; Boulina M; Capecchi MR; Partanen JM; Chen L; Kondo T; Ornitz DM; Trent JC; Eid JE
J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 33983905
[TBL] [Abstract] [Full Text] [Related]
11. Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma.
Momeni-Boroujeni A; Mohammad N; Wolber R; Yip S; Köbel M; Dickson BC; Hensley ML; Leitao MM; Antonescu CR; Benayed R; Ladanyi M; Lee CH; Chiang S
Mod Pathol; 2021 May; 34(5):1008-1016. PubMed ID: 33077922
[TBL] [Abstract] [Full Text] [Related]
12. Genomic Profiling Aids Classification of Diagnostically Challenging Uterine Mesenchymal Tumors With Myomelanocytic Differentiation.
Selenica P; Conlon N; Gonzalez C; Frosina D; Jungbluth AA; Beets-Tan RGH; Rao MK; Zhang Y; Benayed R; Ladanyi M; Solit DB; Chiang S; Hyman DM; Hensley ML; Soslow RA; Weigelt B; Murali R
Am J Surg Pathol; 2021 Jan; 45(1):77-92. PubMed ID: 32889887
[TBL] [Abstract] [Full Text] [Related]
13. Comprehensive characterization of circular RNAs in osteosarcoma cell lines.
Xiong W; Zhang Y; Yu H
Cell Signal; 2020 Jul; 71():109603. PubMed ID: 32199934
[TBL] [Abstract] [Full Text] [Related]
14. Effectiveness of intensive clinical and radiological follow-up in patients with surgically resected NSCLC. Analysis of 2661 patients from the prospective MAGRIT trial.
Conforti F; Pala L; Pagan E; Bagnardi V; Zagami P; Spaggiari L; Catania C; Vansteenkiste J; Giaccone G; De Pas T
Eur J Cancer; 2020 Jan; 125():94-103. PubMed ID: 31841793
[TBL] [Abstract] [Full Text] [Related]
15. Analyses of fgfr3 and PIK3CA mutations in neuroblastomas and the effects of the corresponding inhibitors on neuroblastoma cell lines.
Kostopoulou ON; Holzhauser S; Lange BKA; Ohmayer A; Andonova T; Bersani C; Wickström M; Dalianis T
Int J Oncol; 2019 Dec; 55(6):1372-1384. PubMed ID: 31638167
[TBL] [Abstract] [Full Text] [Related]
16. Hotspot Mutations Detectable by Next-generation Sequencing in Exhaled Breath Condensates from Patients with Lung Cancer.
Youssef O; Knuuttila A; Piirilä P; Böhling T; Sarhadi V; Knuutila S
Anticancer Res; 2018 Oct; 38(10):5627-5634. PubMed ID: 30275180
[TBL] [Abstract] [Full Text] [Related]
17. Anaplastic thyroid carcinoma: an epidemiologic, histologic, immunohistochemical, and molecular single-institution study.
Deeken-Draisey A; Yang GY; Gao J; Alexiev BA
Hum Pathol; 2018 Dec; 82():140-148. PubMed ID: 30075157
[TBL] [Abstract] [Full Text] [Related]
18. Expanded molecular profiling of myxofibrosarcoma reveals potentially actionable targets.
Heitzer E; Sunitsch S; Gilg MM; Lohberger B; Rinner B; Kashofer K; Stündl N; Ulz P; Szkandera J; Leithner A; Liegl-Atzwanger B
Mod Pathol; 2017 Dec; 30(12):1698-1709. PubMed ID: 28776571
[TBL] [Abstract] [Full Text] [Related]
19. Application of Long Noncoding RNAs in Osteosarcoma: Biomarkers and Therapeutic Targets.
Li Z; Dou P; Liu T; He S
Cell Physiol Biochem; 2017; 42(4):1407-1419. PubMed ID: 28715796
[TBL] [Abstract] [Full Text] [Related]
20. Establishment of a novel cellular model for myxofibrosarcoma heterogeneity.
Lohberger B; Stuendl N; Leithner A; Rinner B; Sauer S; Kashofer K; Liegl-Atzwanger B
Sci Rep; 2017 Mar; 7():44700. PubMed ID: 28304377
[TBL] [Abstract] [Full Text] [Related]
[Next]
